AP Biosciences, Inc. (TPEX:6945)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Biotechnology	32.25M		6.99M	137.56M
Biotechnology Growth	-		-94.92%	-
Total	32.25M		6.99M	137.56M
Total Growth	-		-94.92%	-

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
China	32.25M		6.99M	137.56M
China Growth	-		-94.92%	-
Total	32.25M		6.99M	137.56M
Total Growth	-		-94.92%	-

Source: S&P Global Market Intelligence.